{
    "xml": "<topic id=\"PHP78966\" outputclass=\"clinicalMedicinalProductInformation\" type=\"clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information/li-liquid\" basename=\"li-liquid\" title=\"Li-Liquid\">\n<title>Li-Liquid<tm tmtype=\"reg\"/>\n</title>\n<topic id=\"PHP79219\" outputclass=\"indicationsAndDose\" rev=\"1.19\" parent=\"/clinical-medicinal-product-information/li-liquid\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of mania</p>\n<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of bipolar disorder</p>\n<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of recurrent depression</p>\n<p outputclass=\"therapeuticIndication\">Treatment and prophylaxis of aggressive or self-harming behaviour</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight up to 49 kg)</p>\n<p>Initially 509&#8239;mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1&#8239;mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Adult (body-weight 50 kg and above)</p>\n<p>Initially 1.018&#8211;3.054&#8239;g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1&#8239;mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>\n</li>\n<li outputclass=\"patientGroup adult\">\n<p>Elderly</p>\n<p>Initially 509&#8239;mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1&#8239;mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"doseEquivalence\">\n<title>Dose equivalence and conversion</title>\n<p>Lithium citrate tetrahydrate 509&#8239;mg is equivalent to lithium carbonate 200&#8239;mg.</p>\n<p>\n<b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" title=\"Clinical medicinal product information\" namespace=\"/clinical-medicinal-product-information\">Clinical medicinal product information</xref>\n</parents>\n<backlinks/>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#clinicalMedicinalProductInformation\" href=\"#clinicalMedicinalProductInformation\" namespace=\"/clinical-medicinal-product-information\" title=\"Clinical medicinal product information\" count=\"1\" rel=\"link\">Clinical medicinal product information</xref>\n</links>\n</topic>",
    "id": "PHP78966",
    "outputclass": "clinicalMedicinalProductInformation",
    "type": "clinicalMedicinalProductInformation",
    "namespace": "/clinical-medicinal-product-information/li-liquid",
    "basename": "li-liquid",
    "title": "Li-Liquid",
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Treatment and prophylaxis of mania",
                        "html": "Treatment and prophylaxis of mania"
                    },
                    {
                        "textContent": "Treatment and prophylaxis of bipolar disorder",
                        "html": "Treatment and prophylaxis of bipolar disorder"
                    },
                    {
                        "textContent": "Treatment and prophylaxis of recurrent depression",
                        "html": "Treatment and prophylaxis of recurrent depression"
                    },
                    {
                        "textContent": "Treatment and prophylaxis of aggressive or self-harming behaviour",
                        "html": "Treatment and prophylaxis of aggressive or self-harming behaviour"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "Initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1 mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.",
                        "html": "<p>Initially 509&#8239;mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1&#8239;mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>",
                        "ageGroup": "(body-weight up to 49 kg)"
                    },
                    {
                        "textContent": "Initially 1.018&#8211;3.054 g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1 mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.",
                        "html": "<p>Initially 1.018&#8211;3.054&#8239;g daily in 2 divided doses, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1&#8239;mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>",
                        "ageGroup": "(body-weight 50 kg and above)"
                    },
                    {
                        "textContent": "Initially 509 mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1 mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.",
                        "html": "<p>Initially 509&#8239;mg twice daily, dose adjusted to achieve a serum-lithium concentration of 0.4&#8211;1&#8239;mmol/litre 12 hours after a dose on days 4&#8211;7 of treatment, then every week until dosage has remained constant for 4 weeks and every 3 months thereafter, doses are initially divided throughout the day, but once daily administration is preferred when serum-lithium concentration stabilised.</p>",
                        "ageGroup": "elderly"
                    }
                ]
            }
        ],
        "doseEquivalence": [
            {
                "type": "doseEquivalence",
                "title": "Dose equivalence and conversion",
                "textContent": "Lithium citrate tetrahydrate 509 mg is equivalent to lithium carbonate 200 mg.\n\nPreparations vary widely in bioavailability; changing the preparation requires the same precautions as initiation of treatment.",
                "html": "<p>Lithium citrate tetrahydrate 509&#8239;mg is equivalent to lithium carbonate 200&#8239;mg.</p><p>\n<b>Preparations vary widely in bioavailability</b>; changing the preparation requires the same precautions as initiation of treatment.</p>"
            }
        ]
    },
    "backlinks": {},
    "links": {
        "#clinicalMedicinalProductInformation": [
            {
                "id": "clinicalMedicinalProductInformation",
                "label": "Clinical medicinal product information",
                "type": "#clinicalMedicinalProductInformation"
            }
        ]
    }
}